WHITE PAPER

Technology-enabled Approval Acceleration: Spotlighting the ICH S1B Weight of Evidence

The ICH S1B WoE directive is a real game-changer for the pharma industry

In this White Paper you will learn the importance and significance of the recent ICH S1B Guideline, and how technology-enabled approaches, such as Artificial Intelligence (AI) and Machine Learning (ML), can enhance the production of a WoE.

Enter your details below to access the white paper

First Name *

Last Name *

Job Title *

Company *

Email *

Country *

Opt-in to receive periodic industry insights, event invitations, product updates, and other information from Instem.

Comments